Next-generation nanomedicines and nanosimilars: EU regulators' initiatives relating to the development and evaluation of nanomedicinesEHMANN, Falk; SAKAI-KATO, Kumiko; ROBERT, Jean-Louis et al.Nanomedicine (London. Print). 2013, Vol 8, Num 5, pp 849-856, issn 1743-5889, 8 p.Article

Techniques for physicochemical characterization of nanomaterialsLIN, Ping-Chang; LIN, Stephen; WANG, Paul C et al.Biotechnology advances. 2014, Vol 32, Num 4, pp 711-726, issn 0734-9750, 16 p.Conference Paper

Synthetic immunosurveillance systems: Nanodevices to monitor physiological eventsWOAPPI, Yvon L; JANGITI, Rahul; SINGH, Om V et al.Biosensors & bioelectronics. 2014, Vol 61, pp 152-164, issn 0956-5663, 13 p.Article

Exosomes as Immunotheranostic Nanoparticles : EXTRACELLULAR EXOSOMES AND MICROVESICLES IN ALLERGIC AND IMMUNOLOGICAL DISEASESNATASHA, G; GUNDOGAN, Buket; AARON TAN et al.Clinical therapeutics. 2014, Vol 36, Num 6, pp 820-829, issn 0149-2918, 10 p.Article

Nanodelivery Systems for Improved Topical Antimicrobial TherapyBASNET, Purusotam; SKALKO-BASNET, Nataša.Current pharmaceutical design (Print). 2013, Vol 19, Num 41, pp 7237-7243, issn 1381-6128, 7 p.Article

Innovation in Nanomedicine through Materials NanoarchitectonicsKUJAWA, Piotr; WINNIK, Françoise M.Langmuir. 2013, Vol 29, Num 24, pp 7354-7361, issn 0743-7463, 8 p.Article

Pharmacytes : An ideal vehicle for targeted drug deliveryFREITAS, Robert A.Journal of nanoscience and nanotechnology (Print). 2006, Vol 6, Num 9-10, pp 2769-2775, issn 1533-4880, 7 p.Article

Why healthcare open innovation is failing for nanomedicinesEATON, Michael A. W.European journal of nanomedicine (Print). 2013, Vol 5, Num 4, pp 213-215, issn 1662-5986, 3 p.Article

Les nanomédicaments : Nanomédecine: Du labo au marchéFATTAL, Elias; BOCHOT, Amélie; HILLAIREAU, Hervé et al.Biofutur (Puteaux). 2012, Num 333, pp 26-29, issn 0294-3506, 4 p.Article

First cross border conference on nanosciences and materials for health. Nano SMH (21-25 june 2010, Pont-à-Mousson)Cross border conference on nanosciences and materials for health. 2010, 1Vol, 64 p.Conference Proceedings

NEUROSURGERY IN THE REALM OF 10^-9, PART 1: STARDUST AND NANOTECHNOLOGY IN NEUROSCIENCE. CommentaryELDER, James B; LIU, Charles Y; APUZZO, Michael L. J et al.Neurosurgery. 2008, Vol 62, Num 1, pp 1-20, issn 0148-396X, 20 p.Article

NEUROSURGERY IN THE REALM OF 10^-9, PART 2: APPLICATIONS OF NANOTECHNOLOGYTO NEUROSURGERY-PRESENT AND FUTURE. CommentariesELDER, James B; LIU, Charles Y; APUZZO, Michael L. J et al.Neurosurgery. 2008, Vol 62, Num 2, pp 269-285, issn 0148-396X, 17 p.Article

Chemoradiotherapy of Human Tumors: Novel Approaches from NanomedicineWERNER, Michael Edward; FOOTE, Michael Bonner; WANG, Andrew Zhuang et al.Current pharmaceutical design (Print). 2012, Vol 18, Num 19, pp 2830-2837, issn 1381-6128, 8 p.Article

Surface functionalized biocompatible magnetic nanospheres for cancer hyperthermiaXIANQIAO LIU; NOVOSAD, Valentyn; ROZHKOVA, Elena A et al.IEEE transactions on magnetics. 2007, Vol 43, Num 6, pp 2462-2464, issn 0018-9464, 3 p.Conference Paper

Epigenetics advancing personalized nanomedicine in cancer therapySHUJUN LIU.Advanced drug delivery reviews. 2012, Vol 64, Num 13, pp 1532-1543, issn 0169-409X, 12 p.Article

Le business model des biotechnologies est-il adapté à la France ? : LES BIOTECHS FRANÇAISES SONT-ELLES COMPÉTITIVES ?SADI, Nacer-Eddine; CATHERINE, David; THEODOSIOU, Maria et al.Biofutur (Puteaux). 2014, Num 350, pp 32-35, issn 0294-3506, 4 p.Article

Des nanotechnologies pour le diagnostic : Nanomédecine: Du labo au marchéTEXIER, Isabelle; COLL, Jean-Luc; VAUCHIER, Claude et al.Biofutur (Puteaux). 2012, Num 333, pp 37-41, issn 0294-3506, 5 p.Article

Mechanisms of cooperation in cancer nanomedicine: towards systems nanotechnologyHAUERT, Sabine; BHATIA, Sangeeta N.Trends in biotechnology (Regular ed.). 2014, Vol 32, Num 9, pp 448-455, issn 0167-7799, 8 p.Article

Les nanoparticules en radiothérapie : Nanomédecine: Du labo au marchéBILLOTEY, Claire.Biofutur (Puteaux). 2012, Num 333, pp 32-36, issn 0294-3506, 5 p.Article

Block ionomer complexes as prospective nanocontainers for drug deliveryOH, Kyung T; BRONICH, Tatiana K; BROMBERG, Lev et al.Journal of controlled release. 2006, Vol 115, Num 1, pp 9-17, issn 0168-3659, 9 p.Article

CARDIOVASCULAR NANOMEDICINELETOURNEUR, Didier.European journal of nanomedicine (Print). 2014, Vol 6, Num 2, issn 1662-5986, 61 p.Serial Issue

Une mégaprogrammation pour les nanotechnologiesDOUHI, Safi.Biofutur (Puteaux). 2012, Num 333, pp 50-51, issn 0294-3506, 2 p.Article

Nanotechnology for vaccine developmentTOTH, Istvan; SKWARCZYNSKI, Mariusz.Nanomedicine (London. Print). 2014, Vol 9, Num 17, issn 1743-5889, [112 p.]Serial Issue

pH-Sensitive nano-systems for drug delivery in cancer therapyJUAN LIU; YURAN HUANG; KUMAR, Anil et al.Biotechnology advances. 2014, Vol 32, Num 4, pp 693-710, issn 0734-9750, 18 p.Conference Paper

Anticancer nanomedicine and tumor vascular permeability; Where is the missing link?TAURIN, Sebastien; NEHOFF, Hayley; GREISH, Khaled et al.Journal of controlled release. 2012, Vol 164, Num 3, pp 265-275, issn 0168-3659, 11 p.Article